Non-small cell lung cancer harbouring non-resistant uncommon EGFR mutations: Mutation patterns, effectiveness of epidermal growth factor receptor-tyrosine kinase inhibitors and prognostic factors-Reference-Cited by-同舟云学术

Non-small cell lung cancer harbouring non-resistant uncommon EGFR mutations: Mutation patterns, effectiveness of epidermal growth factor receptor-tyrosine kinase inhibitors and prognostic factors

Published:2019-09 Issue: Volume:119 Page:77-86
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Chang Lih-Chyun^ORCID,Lim Chor-Kuan,Chang Lih-Yu,Chen Kuan-Yu,Shih Jin-Yuan,Yu Chong-Jen

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference33 articles.

1. Screening for epidermal growth factor receptor mutations in lung cancer;Rosell;N Engl J Med,2009

2. First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer;Wu;Am J Respir Crit Care Med,2008

3. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers;Shigematsu;J Natl Cancer Inst,2005

4. Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer;Sequist;J Clin Oncol,2007

5. Comparing the effects of afatinib with gefitinib or Erlotinib in patients with advanced-stage lung adenocarcinoma harboring non-classical epidermal growth factor receptor mutations;Shen;Lung Cancer,2017

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the Landscape of Uncommon EGFR Mutations in NSCLC-A Systematic Review;Journal of Thoracic Oncology;2024-07

2. Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment;Cancer Research Communications;2024-03-26

3. Exploring the recent developments of alginate silk fibroin material for hydrogel wound dressing: A review;International Journal of Biological Macromolecules;2023-09

4. Successful treatment of lung adenocarcinoma complicated with a rare compound EGFR mutation L833V/H835L using aumolertinib: a case report and literature review;Frontiers in Pharmacology;2023-08-29

5. Design, Synthesis, and Biological Evaluation of 4H-Pyrido[1,2-a]pyrimidin-4-one Derivatives as Anticancer Agents via ROR1 Inhibition;HETEROCYCLES;2023